Related Experiment Video
Updated: Jan 31, 2026

Isolation and Transplantation of Hematopoietic Stem Cells HSCs
Published on: February 25, 2007
Cytomegalovirus in Pediatric Hematopoietic Stem Cell Transplantation: A Case-Based Panel Discussion of Current
Lara Danziger-Isakov1, Janet Englund2, Michael Green3
1Division of Infectious Diseases, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Ohio.
Abstract:
Cytomegalovirus (CMV) remains a significant contributor to morbidity and death after pediatric solid and stem cell transplantation. Decisions regarding prevention and treatment often lack pediatric-specific data to drive decision making. We present here a case-based discussion around some of these specific topics and focus on approaches to CMV prevention, post-CMV secondary prophylaxis options, and identification and treatment of resistant CMV infection, including emerging antiviral agents and the use of cytotoxic CMV-specific T-cells, in the setting of pediatric hematopoietic stem cell transplantation.
Related Concept Videos
Multipotency of Hematopoietic Stem Cells
Regulation of Hematopoietic Stem Cells
Induced Pluripotent Stem Cells
Wood Panel Products
Adult Stem Cells
Embryonic Stem Cells

